fox2now.com

Missouri lawmakers debate whether clinical trials using psychedelics should proceed and how they should be regulated. The discussion centers on medical research aims, potential benefits, and concerns about safety and oversight while evaluating what evidence-based framework the state can support. The story frames psychedelics as an emerging area of clinical research, contrasting hopes for new treatments with the need for clear rules for trial access and conduct.